Key result
Baylor circulatory support system achieves up to 2-week survival without anticoagulation in preclinical models.
Why the study?
A multipurpose circulatory support system was developed to serve as both temporary and permanent devices in total artificial hearts and ventricular assist devices.
Population
Preclinical models tested with total artificial heart and ventricular assist device
Comparison
Electromechanical total artificial heart vs electromechanical ventricular assist device
Design
Preclinical development study of a multipurpose circulatory support system
Follow-up
Up to 2 weeks
Authors
Loading...
Hypothesis-generating for anticoagulation-free devices in animals; leaves open human translation pending further studies.
The Baylor Multipurpose Circulatory Support System demonstrates early feasibility with 1- to 2-week survival in preclinical testing without anticoagulation.
Shiono et al. (1992) studied End-stage heart disease. Baylor Multipurpose Circulatory Support System (TAH and VAD) was evaluated on Survival. The Baylor multipurpose circulatory support system achieved 1-week survival as an electromechanical total artificial heart and 2-week survival as a ventricular assist device without anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: